Fully Executed Document (3) - Laserfiche WebLink

Home Browse Search

Docusign Envelope lD: 97E7029C-8CD5-4FBF-9DC4-1 837DD2691 89 SCHEDULE A-4 Statement of Work July 1, 2025 - June 30, 2026 1. PURPOSE Support a comprehensive treatment program for incarcerated individuals with Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD), beginning with screening upon entry and ending with seamless transition to the care in the community, with use of Medications for Opioid Use Disorder (MOUD) and Medications for Alcohol Use Disorder (MAUD) at its core. This Contract supports RCW 71.24.599: Opioid use disorder-Citv and countv iails-Fundinq. (wa.qov). Health Equity - This program also intends to address inequities in treatment and recovery services by providing medically necessary treatment to incarcerated individuals. Programs should understand cultural barriers and provide culturally appropriate services. Additionally, this program intends to identify stigma and educate to ensure ongoing collaboration and openness to change. 2. WORK EXPECTATIONS Contractor shall ensure funds are responsibly used towards the Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD) treatment programs in the jail and provide the community standard of care, including, at a minimum, the following core components: 2.1. General Standard of Gare 2.1.1. 2020 ASAM National Practice Guideline for the Treatment of Opioid Use Disorder. 2.1.2. Guidelines for Manaqinq Substance Withdrawal in Jails; 2.1.3. For American lndian/Alaska Native (A|/AN) individuals receiving Medications for Opioid Use Disorder (MOUD) and/or Medications for Alcohol Use Disorder (MAUD) services, Contractor, shall coordinate with the individual's lndian Health Care Provider (IHCP) to ensure the IHCP can participate in treatment and discharge planning, including continuity of care in the nearest IHCP clinically appropriate setting for all AI/AN individuals participating in the program. 2.2. lntake 2.2.1.Screen all newly admitted individuals for risk of acute withdrawal from opioids and alcohol upon intake. MOUD, MAUD, and other medications which support the relief of withdrawal symptoms, such as clonidine, anti-emetics, anti-diarrheals, and analgesics must be offered to individuals at no charge to the individual. Offer initiation of MOUD treatment to individuals who are physically dependent on opioids, may have withdrawal symptoms or have disclosed recent use and anticipate withdrawal. Offer treatment for withdrawal with benzodiazepines to individuals entering the facility who are physically dependent on alcohol, if clinically appropriate. 2.2.2 2.2.3 2.2.4. HCA Contract No. K5885-04 Page 4 of 13